A sovereign antimicrobial platform.
We engage with government, defence and national-security stakeholders on resilience, biothreat preparedness and the strategic value of a UK-developed, broad-spectrum antimicrobial platform.
Biothreat resilience
Broad-spectrum activity validated against bacterial, viral and biofilm targets relevant to public health and operational readiness.
Field-deployable
Stable, water-soluble and shelf-resilient — engineered for forward operating environments and strategic stockpile use.
Sovereign supply
UK-developed, plant-derived feedstock and a defensible IP estate — supporting domestic manufacture and supply security.
Dual-use platform
A single chemistry adaptable across medical, decontamination, preservation and infrastructure-protection use cases.
Confidential briefings available.
Detailed evidence, mechanism and deployment scenarios are shared with qualified government and defence stakeholders under NDA.